Form 4: Hologic Executive Jennifer Schneiders Sells Shares to Cover Tax Obligations

Hologic's President of Diagnostic Solutions, Jennifer Schneiders, sold 507 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Summary

• Jennifer Schneiders, President of Diagnostic Solutions at Hologic Inc., sold 507 shares of common stock on November 14, 2024.
• The sale was executed at a price of $77.54 per share.
• This transaction was to cover tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Ms. Schneiders directly owns 12,096 shares of Hologic common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no significant positive or negative implications for the company's performance or outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total shares owned by the executive, suggesting this is a routine transaction rather than a significant divestment.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors as it is a routine sale of shares for tax purposes.

Key Dates

Keywords

Hologic, insider trading, stock sale, Jennifer Schneiders, restricted stock units, tax obligations, executive transaction, HOLX